Prokarium
Operator of a biopharmaceutical company intended for developing bacterial immunotherapies for cancer. The company's proprietary technology naturally homes to tumors, stimulates anti-tumor immune respo...
Valuation
$0
Share Price
N/A
Total Raised
$88.8M
Last Round
N/A